The role of FDG-PET scan in staging patients with nonsmall cell carcinoma

BackgroundTo assess the role of flourodeoxyglucose–positron-emission tomography (FDG-PET) scan in staging patients with nonsmall cell lung cancer (NSCLC).MethodsWe prospectively studied 400 patients with NSCLC. Each patient underwent a computed tomography (CT) scan of the chest and upper abdomen, other conventional staging studies and had a FDG-PET scan within 1 month before surgery. All suspicious N2 lymph nodes by either chest CT or by FDG-PET...